Oxford BioMedica plc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oxford BioMedica plc with three other
miscellaneous service companies in Europe:
Karo Pharma AB
sales of 347.26 million Swedish Kronor [US$39.48 million]
Brain Biotechnology Research and Information Network AG
(25.04 million Euro [US$27.07 million]
of which 52%
was BioIndustrial), and
Zealand Pharma A/S
based in Denmark
(234.78 million Danish Kroner [US$34.13 million]
During the year ended December of 2016, sales at
Oxford BioMedica plc were £27.78 million (US$34.68 million).
increase of 74.6%
versus 2015, when the company's sales were £15.91 million.
This was the third consecutive year of growth at Oxford BioMedica plc.